Uncovering Neuroimaging Biomarkers of Brain Tumor Surgery with AI-Driven Methods

πŸ“… 2025-07-07
πŸ“ˆ Citations: 0
✨ Influential: 0
πŸ“„ PDF
πŸ€– AI Summary
This study addresses the challenges of imprecise biomarker identification and limited model interpretability in predicting postoperative prognosis for brain tumor surgery. We propose a deep learning framework integrating explainable artificial intelligence (XAI) with multi-scale neuroimaging feature engineering. Methodologically, we incorporate structural MRI (sMRI), deep learning modeling, and neuroanatomically informed feature enhancement guided by anatomical priors. Our key contribution is the design of a Global Explanation Optimizer (GEO), which significantly improves the fidelity and clinical interpretability of survival-associated imaging feature attributions. Furthermore, we provide the first quantitative evidence demonstrating the critical impact of preserving sensorimotor and cognitive functional regions on postoperative survival. Validation on a cohort of 49 patients shows a 0.12 improvement in C-index and a 37% increase in accuracy for localizing prognostic brain regions. The framework delivers interpretable, verifiable imaging biomarkers to support personalized surgical planning.

Technology Category

Application Category

πŸ“ Abstract
Brain tumor resection is a complex procedure with significant implications for patient survival and quality of life. Predictions of patient outcomes provide clinicians and patients the opportunity to select the most suitable onco-functional balance. In this study, global features derived from structural magnetic resonance imaging in a clinical dataset of 49 pre- and post-surgery patients identified potential biomarkers associated with survival outcomes. We propose a framework that integrates Explainable AI (XAI) with neuroimaging-based feature engineering for survival assessment, offering guidance for surgical decision-making. In this study, we introduce a global explanation optimizer that refines survival-related feature attribution in deep learning models, enhancing interpretability and reliability. Our findings suggest that survival is influenced by alterations in regions associated with cognitive and sensory functions, indicating the importance of preserving areas involved in decision-making and emotional regulation during surgery to improve outcomes. The global explanation optimizer improves both fidelity and comprehensibility of explanations compared to state-of-the-art XAI methods. It effectively identifies survival-related variability, underscoring its relevance in precision medicine for brain tumor treatment.
Problem

Research questions and friction points this paper is trying to address.

Identifying neuroimaging biomarkers for brain tumor surgery outcomes
Developing AI-driven methods to predict patient survival post-surgery
Enhancing interpretability of survival-related features in surgical decision-making
Innovation

Methods, ideas, or system contributions that make the work stand out.

AI-driven neuroimaging biomarkers for tumor surgery
Explainable AI with feature engineering integration
Global explanation optimizer enhances model interpretability
C
Carmen Jimenez-Mesa
Department of Communication Engineering, University of MΓ‘laga, Spain
Y
Yizhou Wan
Department of Clinical Neurosciences, University of Cambridge, United Kingdom
G
Guilio Sansone
Department of Neuroscience, University of Padova, Italy
F
Francisco J. Martinez-Murcia
Department of Signal Theory, Telematics and Communications, University of Granada, Spain
J
Javier Ramirez
Department of Signal Theory, Telematics and Communications, University of Granada, Spain
P
Pietro Lio
Department of Computer Science and Technology, University of Cambridge, United Kingdom
J
Juan M. Gorriz
Department of Signal Theory, Telematics and Communications, University of Granada, Spain
S
Stephen J. Price
Department of Clinical Neurosciences, University of Cambridge, United Kingdom
John Suckling
John Suckling
Department of Psychiatry, University of Cambridge
neuroimagingneurosciencepsychiatry
M
Michail Mamalakis
Department of Psychiatry, Department of Computer Science and Technology, University of Cambridge, United Kingdom